Brief: Ampio Reports Positive Results For Ampion Treatment In Covid-19 Patients

Ampio Pharmaceuticals

09/09/2020 14:20

Sept 9 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO REPORTS POSITIVE RESULTS FOR AMPION TREATMENT IN
COVID-19
PATIENTS
    * AMPIO PHARMACEUTICALS INC - AMPION FOUND TO BE SAFE AND
WELL-TOLERATED WITH NO DRUG RELATED ADVERSE EVENTS
    * AMPIO PHARMACEUTICALS INC - STUDY MET ITS PRIMARY ENDPOINT
FOR
SAFETY AND TOLERABILITY OF IV AMPION TREATMENT
    * AMPIO PHARMA - AMPION-TREATED PATIENTS SHOWED GREATER
IMPROVEMENT VERSUS PATIENTS TREATED WITH STANDARD OF CARE
INCLUDING ANTI-VIRAL THERAPIES
    * AMPIO PHARMACEUTICALS - BELIEVE AMPION MAY BE EFFECTIVE IN
INTERRUPTING INFLAMMATORY CASCADE ASSOCIATED WITH COVID-19
    * AMPIO PHARMACEUTICALS INC - PATIENTS WILL BE FOLLOWED OVER
UPCOMING MONTHS TO COMPLETE SAFETY ENDPOINT ASSESSMENTS FOR
PHASE 1 CLINICAL TRIAL

Source text for Eikon:  ID:nPn3fGtxa 
Further company coverage:  AMPE.A 

 ((Reuters.Briefs@thomsonreuters.com;))